Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world.Sironax was founded in 2017 and is based in Beijing, China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 2, 2022 | Series B | $200M | 3 | Gaorong Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaorong Capital | Yes | Series B |
ARCH Venture Partners | — | Series B |
Superstring Capital | — | Series B |